CW July 2000
Volume 9Issue Number 7 July 2000 ISSN 10593802 Less Toxic Regimen Offers Same Survival in Bladder CancerAbstract: In a comparative trial among 405 patients, the combination of gemcitabine and cisplatin is equally effective and less toxic than the standard treatment for patients with locally advanced or metastatic transitional cell carcinoma of the urothelium.
Go to Previous Page Go to Next Page Source & Additional Reading Thirty-Sixth Annual Meeting of the American Society of Clinical Oncology (ASCO) in New Orleans. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
